AAAAAA
Results:
1-7
|
Results: 7
Authors:
Klopfenstein, KJ
Hutchison, C
Clark, C
Young, D
Ruymann, FB
Citation: Kj. Klopfenstein et al., Variables influencing end-of-life care in children and adolescents with cancer, J PED H ONC, 23(8), 2001, pp. 481-486
Authors:
Nathan, PJ
Baker, A
Carr, E
Earle, J
Jones, M
Nieciecki, M
Hutchison, C
Stough, C
Citation: Pj. Nathan et al., Cholinergic modulation of cognitive function in healthy subjects: acute effects of donepezil, a cholinesterase inhibitor, HUM PSYCHOP, 16(6), 2001, pp. 481-483
Authors:
Shochat, SJ
Fremgen, AM
Murphy, SB
Hutchison, C
Donaldson, SS
Haase, GM
Provisor, AJ
Clive-Bumpus, RE
Winchester, DP
Citation: Sj. Shochat et al., Childhood cancer: Patterns of protocol participation in a national survey, CA-A CANC J, 51(2), 2001, pp. 119-130
Authors:
Hutchison, C
Citation: C. Hutchison, Social support: factors to consider when designing studies that measure social support, J ADV NURS, 29(6), 1999, pp. 1520-1526
Authors:
Thavasu, P
Propper, D
McDonald, A
Dobbs, N
Ganesan, T
Talbot, D
Braybrook, J
Caponigro, F
Hutchison, C
Twelves, C
Man, A
Fabbro, D
Harris, A
Balkwill, F
Citation: P. Thavasu et al., The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients, CANCER RES, 59(16), 1999, pp. 3980-3984
Authors:
Twelves, CJ
Gardner, C
Flavin, A
Sludden, J
Dennis, I
de Bono, J
Beale, P
Vasey, P
Hutchison, C
Macham, MA
Rodriguez, A
Judson, I
Bleehen, NM
Citation: Cj. Twelves et al., Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II, BR J CANC, 80(11), 1999, pp. 1786-1791
Authors:
Anastakis, DJ
Regehr, G
Reznick, RK
Cusimano, M
Murnaghan, J
Brown, M
Hutchison, C
Citation: Dj. Anastakis et al., Assessment of technical skills transfer from the bench training model to the human model, AM J SURG, 177(2), 1999, pp. 167-170
Risultati:
1-7
|